• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 2016 年至 2021 年患者病历数据识别复发性耐多药结核病的危险因素:回顾性研究。

Identifying risk factors for recurrent multidrug resistant tuberculosis based on patient's record data from 2016 to 2021: retrospective study.

机构信息

Department of Statistics, College of Natural and Computational Sciences, Dilla University, Dilla, Ethiopia.

Department of Statistics, College of Natural and Computational Sciences, Mattu University, Mattu, Ethiopia.

出版信息

Sci Rep. 2024 Oct 13;14(1):23912. doi: 10.1038/s41598-024-73209-x.

DOI:10.1038/s41598-024-73209-x
PMID:39397064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11471762/
Abstract

Globally, the prevalence of multidrug-resistant tuberculosis (MDR-TB) has been increasing recently. This is a major public health concern, as MDR-TB is more difficult to treat and has poorer outcomes compared to drug-sensitive tuberculosis. The main objective of the study was to identify risk factors for recurrent multidrug-resistant tuberculosis, at Alert Specialized Hospital, Addis Ababa, by using different parametric shared frailty models. From January 2016 to December 2021, a retrospective study was conducted on MDR-TB patients at Alert Specialized Hospital in Addis Ababa. The data for the study were collected from the medical records of MDR-TB patients at the hospital during this time period. Gamma and inverse-Gaussian shared frailty models were used to analyze the dataset, with the exponential, Weibull, and lognormal distributions included as baseline hazard functions. The data were analyzed using R statistical software. The median recurrence time of the patients was 12 months, and 149 (34.3%) had recurrences. The clustering effect was statistically significant for multiple drug-resistant tuberculosis patients' recurrence. According to the Weibull-Inverse-Gaussian model, factors that reduced time to MDR-TB recurrence included lower weight (ɸ = 0.944), smoking (ɸ = 0.045), alcohol use (ɸ = 0.631), hemoptysis (ɸ = 0.041), pneumonia (ɸ = 0.564), previous anti-TB treatment (ɸ = 0.106), rural residence (ɸ = 0.163), and chronic diseases like diabetes (ɸ = 0.442) were associated with faster recurrence. While, higher education (ɸ = 3.525) and age (ɸ = 1.021) extended time to recurrence. For weight increment, smokers and alcohol users, clinical complications of hemoptysis and pneumonia, patients with pulmonary disease who had a history of previous anti-TB treatment, and being rural residents are prognostic factors. There was a significant clustering effect at the Alert Specialized Hospital in Addis Ababa, Ethiopia. The Weibull-Inverse Gaussian Shared Frailty Model was chosen as the best model for predicting the time to recurrence of MDR-TB.

摘要

全球范围内,耐多药结核病(MDR-TB)的患病率最近一直在上升。这是一个主要的公共卫生关注点,因为与敏感结核病相比,MDR-TB 更难治疗,且预后更差。本研究的主要目的是使用不同的参数共享脆弱性模型,确定在亚的斯亚贝巴 Alert 专科医院复发性耐多药结核病的危险因素。2016 年 1 月至 2021 年 12 月,对亚的斯亚贝巴 Alert 专科医院的耐多药结核病患者进行了回顾性研究。本研究的数据来自该医院在此期间的耐多药结核病患者的病历。使用伽马和逆高斯共享脆弱性模型来分析数据集,其中包括指数、威布尔和对数正态分布作为基线危险函数。数据分析使用 R 统计软件进行。患者的中位复发时间为 12 个月,有 149 人(34.3%)复发。多重耐药结核病患者的复发存在统计学显著的聚类效应。根据威布尔-逆高斯模型,降低耐多药结核病复发时间的因素包括较低的体重(ɸ = 0.944)、吸烟(ɸ = 0.045)、饮酒(ɸ = 0.631)、咯血(ɸ = 0.041)、肺炎(ɸ = 0.564)、以前的抗结核治疗(ɸ = 0.106)、农村居住(ɸ = 0.163)和糖尿病等慢性病(ɸ = 0.442)与更快的复发有关。而较高的教育程度(ɸ = 3.525)和年龄(ɸ = 1.021)则延长了复发时间。对于体重增加、吸烟者和饮酒者、咯血和肺炎的临床并发症、以前有抗结核治疗史的肺部疾病患者以及农村居民来说,这些都是预后因素。在埃塞俄比亚亚的斯亚贝巴的 Alert 专科医院存在显著的聚类效应。威布尔-逆高斯共享脆弱性模型被选为预测耐多药结核病复发时间的最佳模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/98cfd27e6dc7/41598_2024_73209_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/7d5449f9cc2d/41598_2024_73209_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/1cee9ebdcd1b/41598_2024_73209_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/c93d6c34852d/41598_2024_73209_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/6ee76c355468/41598_2024_73209_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/ef15cd0d6b89/41598_2024_73209_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/00ebefb96fce/41598_2024_73209_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/6285db9c6293/41598_2024_73209_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/e9afd4228420/41598_2024_73209_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/98cfd27e6dc7/41598_2024_73209_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/7d5449f9cc2d/41598_2024_73209_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/1cee9ebdcd1b/41598_2024_73209_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/c93d6c34852d/41598_2024_73209_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/6ee76c355468/41598_2024_73209_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/ef15cd0d6b89/41598_2024_73209_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/00ebefb96fce/41598_2024_73209_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/6285db9c6293/41598_2024_73209_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/e9afd4228420/41598_2024_73209_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e0/11471762/98cfd27e6dc7/41598_2024_73209_Fig9_HTML.jpg

相似文献

1
Identifying risk factors for recurrent multidrug resistant tuberculosis based on patient's record data from 2016 to 2021: retrospective study.基于 2016 年至 2021 年患者病历数据识别复发性耐多药结核病的危险因素:回顾性研究。
Sci Rep. 2024 Oct 13;14(1):23912. doi: 10.1038/s41598-024-73209-x.
2
Modeling Time to Death of Patients with Multidrug-Resistant Tuberculosis at Saint Peter's Specialized Hospital.建模圣彼得专科医院耐多药结核病患者的死亡时间。
J Res Health Sci. 2021 May 19;21(2):e00513. doi: 10.34172/jrhs.2021.50.
3
Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.埃塞俄比亚亚的斯亚贝巴警报综合专科医院耐多药结核病患者痰培养转化时间的决定因素:一项回顾性队列研究。
PLoS One. 2024 May 31;19(5):e0304507. doi: 10.1371/journal.pone.0304507. eCollection 2024.
4
Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study.亚的斯亚贝巴接受一线治疗的患者中耐多药结核病的决定因素:一项病例对照研究。
BMC Public Health. 2013 Aug 28;13:782. doi: 10.1186/1471-2458-13-782.
5
Predictors of multidrug resistant tuberculosis among adult patients at Saint Peter Hospital Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴圣彼得医院成年患者耐多药结核病的预测因素
Pan Afr Med J. 2016 Nov 26;25(Suppl 2):5. doi: 10.11604/pamj.supp.2016.25.2.9203. eCollection 2016.
6
Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia.埃塞俄比亚东绍阿地区耐多药结核病治疗患者中出现耐多药结核病的危险因素。
BMC Public Health. 2018 Apr 2;18(1):422. doi: 10.1186/s12889-018-5371-3.
7
Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.来自埃塞俄比亚的耐多药结核病疑似患者中结核分枝杆菌菌株的耐药模式及相关危险因素。
PLoS One. 2018 Jun 4;13(6):e0197737. doi: 10.1371/journal.pone.0197737. eCollection 2018.
8
Application of Parametric Shared Frailty Models to Analyze Time-to-Death of Gastric Cancer Patients.参数共享脆弱性模型在分析胃癌患者死亡时间中的应用。
J Gastrointest Cancer. 2023 Mar;54(1):104-116. doi: 10.1007/s12029-021-00775-y. Epub 2022 Jan 22.
9
Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.预测埃塞俄比亚奥罗米亚地区耐多药结核病患者不良治疗结局的时间的因素。
PLoS One. 2019 Oct 30;14(10):e0224025. doi: 10.1371/journal.pone.0224025. eCollection 2019.
10
Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia.与埃塞俄比亚一家三级武装部队转诊和教学医院的耐多药结核病(MDR-TB)相关的风险因素。
BMC Infect Dis. 2018 May 31;18(1):249. doi: 10.1186/s12879-018-3167-9.

引用本文的文献

1
Tuberculosis treatment adherence and associated factors in the Butha-Buthe district, Lesotho: a retrospective cohort study.莱索托布塔布泰区结核病治疗依从性及相关因素:一项回顾性队列研究
Pan Afr Med J. 2025 Apr 2;50:91. doi: 10.11604/pamj.2025.50.91.46218. eCollection 2025.
2
Epidemiological characteristics and risk factors analysis of multidrug-resistant tuberculosis among tuberculosis population in Huzhou City, Eastern China.中国东部湖州市结核病患者中耐多药结核病的流行病学特征及危险因素分析
Open Life Sci. 2025 Mar 22;20(1):20251081. doi: 10.1515/biol-2025-1081. eCollection 2025.

本文引用的文献

1
Multidrug-resistant tuberculosis.耐多药结核病。
Nat Rev Dis Primers. 2024 Mar 24;10(1):22. doi: 10.1038/s41572-024-00504-2.
2
Trends in the incidence and prevalence of dysphagia requiring medical attention among adults in South Korea, 2006-2016: A nationwide population study.2006-2016 年韩国需要医疗关注的成年人吞咽困难发病率和流行率趋势:一项全国性人口研究。
PLoS One. 2023 Jun 28;18(6):e0287512. doi: 10.1371/journal.pone.0287512. eCollection 2023.
3
Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets.
结核病:发病机制、现行治疗方案及新药靶点。
Int J Mol Sci. 2023 Mar 8;24(6):5202. doi: 10.3390/ijms24065202.
4
Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study.利用全国性队列研究确定韩国结核病复发的相关风险因素。
PLoS One. 2022 Jun 16;17(6):e0268290. doi: 10.1371/journal.pone.0268290. eCollection 2022.
5
High mortality among patients hospitalized for drug-resistant tuberculosis with acquired second-line drug resistance and high HIV prevalence.耐多药结核病患者住院死亡率高,且存在获得性二线药物耐药和高 HIV 流行率。
HIV Med. 2022 Nov;23(10):1085-1097. doi: 10.1111/hiv.13318. Epub 2022 May 24.
6
Application of Parametric Shared Frailty Models to Analyze Time-to-Death of Gastric Cancer Patients.参数共享脆弱性模型在分析胃癌患者死亡时间中的应用。
J Gastrointest Cancer. 2023 Mar;54(1):104-116. doi: 10.1007/s12029-021-00775-y. Epub 2022 Jan 22.
7
Modeling Time to Death of Patients with Multidrug-Resistant Tuberculosis at Saint Peter's Specialized Hospital.建模圣彼得专科医院耐多药结核病患者的死亡时间。
J Res Health Sci. 2021 May 19;21(2):e00513. doi: 10.34172/jrhs.2021.50.
8
A Case Study on Modeling the Time to Recurrence of Gastric Cancer Patients.胃癌患者复发时间建模的案例研究。
J Gastrointest Cancer. 2022 Mar;53(1):218-228. doi: 10.1007/s12029-021-00684-0. Epub 2021 Aug 11.
9
Strategies to Combat Multi-Drug Resistance in Tuberculosis.结核病的多药耐药性防治策略。
Acc Chem Res. 2021 May 18;54(10):2361-2376. doi: 10.1021/acs.accounts.0c00878. Epub 2021 Apr 22.
10
Social determinants of multidrug-resistant tuberculosis: A scoping review and research gaps.耐多药结核病的社会决定因素:范围综述和研究差距。
Indian J Tuberc. 2021 Jan;68(1):99-105. doi: 10.1016/j.ijtb.2020.09.016. Epub 2020 Sep 17.